Will a Vaccine Be the End of COVID-19?

October 22, 2020 | Brandon Von Feldt, CFA, Research Analyst

Simmering in the background of the presidential race and stimulus talks remains a crucial step towards fully re-opening the country: vaccine progress. Many experts view the development of a vaccine as the key to finally ending the battle against COVID-19. With a commercially available vaccine anticipated as early as April of 2021, it seemed that we were drawing nearer to the end of restrictions on large gatherings. People would be able to attend sporting events, weddings, and graduations again in a return to more normal life. However, in a startling recent poll of over 34,000 people regarding their interest in receiving a government-approved vaccine, over half said that they would not or are not sure that they would want to receive the vaccine.

The stark difference in responses seems to correlate with education level, as shown in the charts above. There is a significant increase in wanting to receive the vaccine on behalf of people whose education includes a college degree. For education levels below college, the results were much more mixed about receptivity to a vaccine. The most commonly cited reservations were accessibility (cost, wait time, proximity of distribution center/medical office) and effectiveness. Although this was just one poll, it appears that the release of a vaccine may not completely stem the pandemic unless there is a dramatic reversal in vaccine sentiment over the coming months.

Print PDF > Will a Vaccine Be the End of COVID-19?


The opinions expressed herein are those of Marquette Associates, Inc. (“Marquette”), and are subject to change without notice. This material is not financial advice or an offer to purchase or sell any product. Marquette reserves the right to modify its current investment strategies and techniques based on changing market dynamics or client needs.

Brandon Von Feldt, CFA
Research Analyst

Get to Know Brandon

Related Content


The Dollar Returns to Trend (and Could Go Lower)

The dollar has enjoyed an impressive run during the last few years on the backs of trade restrictions, off-cycle expansionary…


Welcome to Lockdown 2.0

As the market and world-at-large were elated by Pfizer’s announcement of positive trial results for its COVID-19 vaccine this week,…


What Does the Biden Win Mean for Financial Markets?

On Saturday, November 7th, Joe Biden was declared the winner of the presidential election and will become the 46th president…


Early Voter Turnout

Of the many reasons the 2020 election may make history, expected record voter turnout is perhaps the best. By October…


Record Growth During Third Quarter, but Will It Continue?

In this week’s chart of the week, we look at the estimated growth of Gross Domestic Product (GDP) — the…


Equities Falter Amid Uncertainty

October has been a tale of two months for equity market participants. While the first half of the month saw…

More articles

Subscribe to Research Email Alerts

Research Email Alert Subscription

Research alerts keep you updated on our latest research publications. Simply enter your contact information, choose the research alerts you would like to receive and click Subscribe. Alerts will be sent as research is published.

We respect your privacy. We will never share or sell your information.

Thank You

We appreciate your interest in Marquette Associates.

If you have questions or need further information, please contact us directly and we will respond to your inquiry within 24 hours.

Contact Us >